Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inhibrx Biosciences, Inc. | 15,000 | reported | 28 May 2025 | tx 5+269,564 |
| Nicholas-Applegate Equity & Convertible Income Fund | 7,209 | reported | 11 Aug 2020 | tx 50+20,000−20,000 |
| NICHOLAS APPLEGATE CONVERTIBLE & INCOME FUND | 0 | reported | 25 Jun 2014 | tx 16+19,300−15,000 |
| Inhibrx, Inc. | 0 | reported | 30 May 2024 | tx 10+127,422−803,782 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2025 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 15,000 | 0.00 USD | deriv |
| 22 Aug 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 15,188 | 12.89 USD | first after silence |
| 23 Aug 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 59,812 | 14.07 USD | anomaly |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 598,257 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 17,259 | — | deriv |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 15,000 | — | deriv |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 15,000 | — | deriv |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 15,000 | — | deriv |
| 29 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 149,564 | — | |
| 30 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 30,000 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | Inhibrx, Inc. | 15,000 | 0.00 USD | deriv |
| 25 May 2022 | GRANT_AWARD | Inhibrx, Inc. | 15,000 | 0.00 USD | deriv |
| 07 Jun 2021 | GRANT_AWARD | Inhibrx, Inc. | 15,000 | 0.00 USD | deriv |
| 21 Aug 2020 | CONVERSION | Inhibrx, Inc. | 82,422 | 0.00 USD | |
| 21 Aug 2020 | CONVERSION | Inhibrx, Inc. | 143,266 | 0.00 USD | deriv |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 4,000 | 24.63 USD | |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 10,000 | 24.68 USD | |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 100 | 24.69 USD | |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 100 | 24.67 USD | |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 800 | 24.66 USD | |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 1,791 | 24.70 USD | |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 600 | 24.64 USD | |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 709 | 24.66 USD | |
| 11 Aug 2020 | SALE | Nicholas-Applegate Equity & Convertible Income Fund | 1,900 | 24.64 USD | |
| 25 Jun 2014 | SALE | NICHOLAS APPLEGATE CONVERTIBLE & INCOME FUND | 2,500 | 10.57 USD |
2 purchases reported after at least 12 months of silence — most recent on 22 Aug 2024.